Cargando…

Expansion and Evaluation of Pharmacist Services in Primary Care

Challenges with primary care access and overextended providers present opportunities for pharmacists as patient care extenders for chronic disease management. The primary objective was to align primary care pharmacist services with organizational priorities and improve patient clinical outcomes. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Hartkopf, Katherine J., Heimerl, Kristina M., McGowan, Kayla M., Arndt, Brian G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7559880/
https://www.ncbi.nlm.nih.gov/pubmed/32707794
http://dx.doi.org/10.3390/pharmacy8030124
_version_ 1783594961784012800
author Hartkopf, Katherine J.
Heimerl, Kristina M.
McGowan, Kayla M.
Arndt, Brian G.
author_facet Hartkopf, Katherine J.
Heimerl, Kristina M.
McGowan, Kayla M.
Arndt, Brian G.
author_sort Hartkopf, Katherine J.
collection PubMed
description Challenges with primary care access and overextended providers present opportunities for pharmacists as patient care extenders for chronic disease management. The primary objective was to align primary care pharmacist services with organizational priorities and improve patient clinical outcomes. The secondary objective was to develop a technological strategy for service evaluation. An interdisciplinary workgroup developed primary care pharmacist services focused on improving performance measures and supporting the care team in alignment with ongoing population health initiatives. Pharmacist collaborative practice agreements (CPAs) were developed and implemented. An electronic dashboard was developed to capture service outcome measures. Blood pressure control to <140/90 mmHg was achieved in 74.15% of patients who engaged with primary care pharmacists versus 41.53% of eligible patients electing to follow usual care pathways. Appropriate statin use was higher in patients engaged with primary care pharmacists than in eligible patients electing to follow usual care pathways both for diabetes and ischemic vascular disease (12.4% and 2.2% higher, respectively). Seventeen of 54 possible process and outcome measures were identified and incorporated into an electronic dashboard. Primary care pharmacist services improve hypertension control and statin use. Service outcomes can be measured with discrete data from the electronic health record (EHR), and should align with organizational priorities.
format Online
Article
Text
id pubmed-7559880
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-75598802020-10-22 Expansion and Evaluation of Pharmacist Services in Primary Care Hartkopf, Katherine J. Heimerl, Kristina M. McGowan, Kayla M. Arndt, Brian G. Pharmacy (Basel) Article Challenges with primary care access and overextended providers present opportunities for pharmacists as patient care extenders for chronic disease management. The primary objective was to align primary care pharmacist services with organizational priorities and improve patient clinical outcomes. The secondary objective was to develop a technological strategy for service evaluation. An interdisciplinary workgroup developed primary care pharmacist services focused on improving performance measures and supporting the care team in alignment with ongoing population health initiatives. Pharmacist collaborative practice agreements (CPAs) were developed and implemented. An electronic dashboard was developed to capture service outcome measures. Blood pressure control to <140/90 mmHg was achieved in 74.15% of patients who engaged with primary care pharmacists versus 41.53% of eligible patients electing to follow usual care pathways. Appropriate statin use was higher in patients engaged with primary care pharmacists than in eligible patients electing to follow usual care pathways both for diabetes and ischemic vascular disease (12.4% and 2.2% higher, respectively). Seventeen of 54 possible process and outcome measures were identified and incorporated into an electronic dashboard. Primary care pharmacist services improve hypertension control and statin use. Service outcomes can be measured with discrete data from the electronic health record (EHR), and should align with organizational priorities. MDPI 2020-07-22 /pmc/articles/PMC7559880/ /pubmed/32707794 http://dx.doi.org/10.3390/pharmacy8030124 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Hartkopf, Katherine J.
Heimerl, Kristina M.
McGowan, Kayla M.
Arndt, Brian G.
Expansion and Evaluation of Pharmacist Services in Primary Care
title Expansion and Evaluation of Pharmacist Services in Primary Care
title_full Expansion and Evaluation of Pharmacist Services in Primary Care
title_fullStr Expansion and Evaluation of Pharmacist Services in Primary Care
title_full_unstemmed Expansion and Evaluation of Pharmacist Services in Primary Care
title_short Expansion and Evaluation of Pharmacist Services in Primary Care
title_sort expansion and evaluation of pharmacist services in primary care
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7559880/
https://www.ncbi.nlm.nih.gov/pubmed/32707794
http://dx.doi.org/10.3390/pharmacy8030124
work_keys_str_mv AT hartkopfkatherinej expansionandevaluationofpharmacistservicesinprimarycare
AT heimerlkristinam expansionandevaluationofpharmacistservicesinprimarycare
AT mcgowankaylam expansionandevaluationofpharmacistservicesinprimarycare
AT arndtbriang expansionandevaluationofpharmacistservicesinprimarycare